Effect of exenatide on the pharmacokinetics of a combination oral contraceptive in healthy women: an open-label, randomised, crossover trial

BACKGROUND: Consistent with its effect on gastric emptying, exenatide, an injectable treatment for type 2 diabetes, may slow the absorption rate of concomitantly administered oral drugs resulting in a decrease in maximum concentration (C(max)). This study evaluated the drug interaction potential of...

Descripción completa

Detalles Bibliográficos
Autores principales: Kothare, Prajakti A, Seger, Mary E, Northrup, Justin, Mace, Kenneth, Mitchell, Malcolm I, Linnebjerg, Helle
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2012
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3378442/
https://www.ncbi.nlm.nih.gov/pubmed/22429273
http://dx.doi.org/10.1186/1472-6904-12-8

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3378442/
https://www.ncbi.nlm.nih.gov/pubmed/22429273
http://dx.doi.org/10.1186/1472-6904-12-8

Ejemplares similares